G Medical Innovations (ASX:GMV) - CEO, Dr Yacov Geva
CEO, Dr Yacov Geva
Source: Globes – Israel
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Mobile health company G Medical Innovations (GMV) has added a new revenue stream to its Independent Diagnostic Testing Facilities (IDTF) platform
  • This platform is a patient monitoring service which allows hospital staff to keep track of a patient’s vital signs remotely
  • G Medical has today announced that it will offer remote patient monitoring services to patients undergoing transcatheter aortic valve replacement (TAVR) treatment
  • Hospitals can now monitor pre and post TAVR patients through G Medical’s AECG Patch technology and mobile cardiac telemetry (MCT) device
  • G Medical is steady on the market and shares are currently trading for 4.2 cents each

Mobile health company G Medical Innovations (GMV) has added a new revenue stream to its Independent Diagnostic Testing Facilities (IDTF) platform.

This platform is a patient monitoring service which allows hospital staff to keep track of a patient’s vital signs remotely.

G Medical has today announced that it will offer remote patient monitoring services to patients undergoing transcatheter aortic valve replacement (TAVR) treatment.

Hospitals can now monitor pre and post TAVR patients through G Medical’s AECG Patch technology and mobile cardiac telemetry (MCT) device.

Additionally, G Medical will receive reimbursements for the service and the price will vary depending on the length of the monitoring period.

“Providing hospital partners with the ability to monitor patients undergoing TAVR treatment through our IDTF platform is another valuable revenue channel,” CEO Dr Yacov Geva said.

“As the addressable market for telehealth grows, we are very confident IDTF will continue to scale up. We are making excellent headway in the U.S. university hospital market and our large sales team is identifying many more opportunities for growth,” he added.

G Medical is steady on the market and shares are trading for 4.2 cents each at 12:25 pm AEST.

GMV by the numbers
More From The Market Online

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…